Tue, Aug 20 2:37pm

Y-mAbs Therapeutics Inc [YMAB]
$27.28 0.61 (2.19%)

YMAB Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 940 Million
YMAB Description

Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.

Visit Website

YMAB Earnings

EPS -0.53 P/E Ratio 0.00
Previous Earnings Fri, May 10, 2019
Latest Earnings Wed, Aug 14, 2019 (6 days ago) +6.24%

YMAB Dividend

Yield --
Ex-Date --
Pay Date --
History --

YMAB Charts

1 Year
Dec 24, 2018
Oct 2, 2018

Symbol Price Day % YTD %
YMAB $27.28 -2.19% 49.81%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy